Immune Modulation by Bacterial Autolysins
细菌自溶素的免疫调节
基本信息
- 批准号:7187340
- 负责人:
- 金额:$ 37.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:ARHGEF5 geneAcuteAddressAffectAnimalsAnti-Bacterial AgentsAnti-Inflammatory AgentsAnti-inflammatoryAntibacterial ResponseApplications GrantsAttenuatedAutolysinBacillus anthracisBacteriaBacterial InfectionsBiochemicalBiological ProcessBioterrorismCategoriesCell surfaceCellsCellular ImmunityChronicComplementCultured CellsCytokine GeneDevelopmentDigestionDiseaseEffectivenessElementsEndopeptidasesEngineeringFamilyGene ExpressionGenerationsGoalsGrantGrowthHumanIFNAR1 geneImmuneImmune responseImmunityInfectionInflammationInflammatoryInflammatory ResponseInterleukin-6LengthListeria monocytogenesMacrophage ActivationMammalian CellMapsMediatingMeningitisMicrobeModelingModificationMolecularMusNatural ImmunityNumbersPeptidesPeptidoglycanPhylogenetic AnalysisProtein FamilyProtein SecretionProteinsSepticemiaSideSpecificitySpontaneous abortionStimulusStructureSystemTestingTherapeuticTissuesVaccinationVacuoleVirulenceantimicrobialbasecell typecytokinecytosolic receptorimmunoregulationmacrophagemicrobialmutantnovelnovel therapeuticspathogenpathogenic bacteriareceptorresponsesmall moleculesugartissue/cell culturevector vaccine
项目摘要
DESCRIPTION (provided by applicant): The SecA2 auxiliary protein secretion system is required for secretion of virulence promoting proteins from a number of Gram-positive pathogens, including Bacillus anthracis (category A) and Listeria monocytogenes (category B). We identified two SecA2-dependent autolytic proteins that promote virulence of L. monocytogenes in infected animals, yet do not affect the growth of this bacterium in tissue culture cells. The virulence of engineered bacterial mutants lacking p60 was restored by expression of full-length p60, but not by expression of a truncated, catalytically inactive protein. The catalytic specificity of p60 predicts that it digests peptidoglycan (PGN) to generate or destroy immune modulating PGN fragments (muropeptides), including respectively muramyl di- and tri-peptides (MDP and MTP). MDP and MTP influence mammalian cell cytokine responses by acting on cytosolic proteins of the Nod family. We have found that p60- expressing bacteria and small molecules released from these bacteria enhance the induction of specific immune-regulatory cytokines by macrophages. In this grant proposal we investigate how p60 promotes virulence and affects host innate immune responses to infection. Our first Aim will identify features of p60 that are required for PGN digestion and for its effects on bacterial virulence and cytokine gene expression. Our second Aim investigates the structure and phylogenetic distribution of a p60-dependent biologically active muropeptide or small molecule and tests whether responses to this molecule require known muropeptide-responsive Nod family proteins. For our third Aim, we investigate a potential mechanism for p60's effects on bacterial virulence by determining how expression of p60 and cytokines induced by p60 affect macrophage responses to activating stimuli. Our studies will define the mechanisms by which this bacterial autolysin contributes to the virulence of a clinically important bacterial pathogen and begin to explore whether similar mechanisms promote virulence of other Gram-positive pathogens, including potential agents of bioterrorism.
The mechanisms used by pathogenic bacteria to cause disease include strategies to subvert host immune responses. A subversive strategy that may be common to a number of deadly bacteria is studied in this grant. Our studies will define the molecular basis for this strategy of immune subversion and may thus reveal novel therapeutic avenues to modulate inflammation during bacterial infection, vaccination, and chronic inflammatory diseases.
描述(由申请人提供):SecA2辅助蛋白分泌系统用于从许多革兰氏阳性病原体中分泌促毒蛋白,包括炭疽芽孢杆菌(a类)和单核增生李斯特菌(B类)。我们鉴定了两种依赖seca2的自溶蛋白,它们在感染动物体内促进单核增生乳杆菌的毒力,但不影响该细菌在组织培养细胞中的生长。缺乏p60的工程细菌突变体的毒力可以通过表达全长p60来恢复,但不能通过表达截断的催化活性蛋白来恢复。p60的催化特异性预示着它可以消化肽聚糖(PGN)来产生或破坏免疫调节的PGN片段(多肽),分别包括二肽和三肽(MDP和MTP)。MDP和MTP通过作用于Nod家族的细胞质蛋白来影响哺乳动物细胞的细胞因子反应。我们发现表达p60的细菌和这些细菌释放的小分子增强了巨噬细胞对特异性免疫调节细胞因子的诱导。在这项拨款提案中,我们研究p60如何促进毒力和影响宿主对感染的先天免疫反应。我们的第一个目标是确定p60的特征,这些特征是PGN消化所必需的,以及它对细菌毒力和细胞因子基因表达的影响。我们的第二个目标是研究p60依赖性生物活性多肽或小分子的结构和系统发育分布,并测试对该分子的反应是否需要已知的多肽反应Nod家族蛋白。对于我们的第三个目标,我们通过确定p60和由p60诱导的细胞因子的表达如何影响巨噬细胞对激活刺激的反应来研究p60对细菌毒力影响的潜在机制。我们的研究将确定这种细菌自溶素对临床重要细菌病原体的毒力的作用机制,并开始探索类似的机制是否会促进其他革兰氏阳性病原体的毒力,包括潜在的生物恐怖主义病原体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laurel L Lenz其他文献
Laurel L Lenz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laurel L Lenz', 18)}}的其他基金
Dendritic cell targeting by bacterial LysM proteins to suppress inflammation
树突状细胞通过细菌 LysM 蛋白靶向抑制炎症
- 批准号:
10750594 - 财政年份:2023
- 资助金额:
$ 37.87万 - 项目类别:
Role of IFNs and IFNGR in susceptibility to bacteria in Down syndrome
IFN 和 IFNGR 在唐氏综合症细菌易感性中的作用
- 批准号:
10356944 - 财政年份:2021
- 资助金额:
$ 37.87万 - 项目类别:
NK cell IL-10 production during bacterial infections
细菌感染期间 NK 细胞产生 IL-10
- 批准号:
9915847 - 财政年份:2017
- 资助金额:
$ 37.87万 - 项目类别:
NK cell IL-10 production during bacterial infections
细菌感染期间 NK 细胞产生 IL-10
- 批准号:
10132971 - 财政年份:2017
- 资助金额:
$ 37.87万 - 项目类别:
NK cell IL-10 production during bacterial infections
细菌感染期间 NK 细胞产生 IL-10
- 批准号:
9893333 - 财政年份:2017
- 资助金额:
$ 37.87万 - 项目类别:
IFNGR Down Regulation as a Host Target for Therapy of Infectious Diseases
IFNGR 下调作为传染病治疗的宿主靶标
- 批准号:
8898936 - 财政年份:2014
- 资助金额:
$ 37.87万 - 项目类别:
Active Subversion of Innate Immunity by Bacterial LysM Protein
细菌 LysM 蛋白主动颠覆先天免疫
- 批准号:
8887925 - 财政年份:2014
- 资助金额:
$ 37.87万 - 项目类别:
Non-canonical responses to IFNab in the suppression of macrophage immunity
IFNab 抑制巨噬细胞免疫的非典型反应
- 批准号:
8882969 - 财政年份:2014
- 资助金额:
$ 37.87万 - 项目类别:
IFNGR Down Regulation as a Host Target for Therapy of Infectious Diseases
IFNGR 下调作为传染病治疗的宿主靶点
- 批准号:
8912973 - 财政年份:2014
- 资助金额:
$ 37.87万 - 项目类别:
Non-canonical responses to IFNab in the suppression of macrophage immunity
IFNab 抑制巨噬细胞免疫的非典型反应
- 批准号:
8430416 - 财政年份:2013
- 资助金额:
$ 37.87万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 37.87万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 37.87万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 37.87万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 37.87万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 37.87万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 37.87万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 37.87万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 37.87万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 37.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 37.87万 - 项目类别:
Standard Grant